INVIZA
INVIZA Health is an early-stage MedTech company building self-charging smart insoles with embedded medical-grade optical sensors and edge/cloud AI for remote patient monitoring, digital therapeutics, and defense applications targeting healthcare providers, military, and athletics organizations.
- Company typePrivate
- Founded2020
- HeadquartersFairport, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What INVIZA does
INVIZA Corporation, operating as INVIZA Health, is an early-stage MedTech company developing the INVIZA CARE M1.0 unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform. The platform centers on self-charging smart insoles (InvizaSoles) that embed medical-grade optical sensors, force sensors, a 9-axis IMU, Bluetooth Low Energy, and LTE cellular radios, paired with patient and caregiver mobile apps (InvizaCare and InvizaSafe), a HIPAA- and DoD-secure cloud (InvizaCloud) running AI/ML predictive analytics (PredictiveWellness), and clinical web dashboards (InvizaPortal). The proprietary SmartPower system uses lead-free piezoelectric materials to convert the wearer's steps into electrical energy, eliminating external charging and addressing compliance failures common in wrist-based RPM devices.
INVIZA monetizes through a combined hardware-plus-software model, selling or licensing the insole hardware to enterprise buyers while generating recurring revenue from cloud-based RPM and DTx software services and clinical dashboards. Go-to-market is enterprise field sales targeting three primary verticals: healthcare providers (Hospital-at-Home, RPM, telehealth, concierge, senior and rural care), defense and military (readiness tracking, post-acute monitoring, VA applications), and athletics/sports medicine. Distribution is direct B2B with stated intent to build channel partnerships, augmented by heavy event-driven presence at HLTH, Health 2.0 Dubai, and DSI's DoD/VA Government HIT Summit.
The company is privately held, headquartered in Cambridge, Massachusetts, with a development and manufacturing center in Fairport (Rochester), New York. Leadership includes founder/CEO/CTO Robert G. Andosca, Ph.D. (prior founder of MicroGen Systems, acquired in 2017), surrounded by a board with credible industry signal — IEEE Medal of Honor recipient Kurt Petersen (co-founder Cepheid, SiTime), former Adidas VP Qaizar Hassonjee, and former Kansas Governor Dr. Jeffrey Colyer — while Kathy Ireland serves as Chief Global Brand Strategist via the kiSBN partnership. The firm is actively soliciting seed-stage capital from accredited angels and strategic investors and has not disclosed revenue.
INVIZA firmographics
Firmographics- Name
- INVIZA
- Legal name
- INVIZA Corporation
- Website
- https://inviza.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- INVIZA Health is an early-stage MedTech company building self-charging smart insoles with embedded medical-grade optical sensors and edge/cloud AI for remote patient monitoring, digital therapeutics, and defense applications targeting healthcare providers, military, and athletics organizations.
- Ownership category
- akta.pro rank
INVIZA industry classification
Industry- Product category
- Remote Patient Monitoring Platform
- NAICS
- Home Health Care Services (621610), Services for the Elderly and Persons with Disabilities (624120)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Remote Patient Monitoring (RPM) Platforms & Services (HLACAPAA)
- akta.pro secondary industries
- Chronic Care & Remote Patient Monitoring (RPM) Platforms (HLALABAF), Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows) (HLALAFAH), Care Coordination, Escalation & Clinical Workflow for RPM (HLACAFAI), AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM)
Keywords
Where INVIZA is headquartered
LocationHeadquarters
- HQ city
- Fairport
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
INVIZA business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales
Revenue model
- INVIZA CARE M1.0 Platform: Remote Health Monitoring platform comprising self-charging smart insoles (hardware), patient mobile apps, cloud platform, and clinical dashboards. Hardware sales combined with software/subscription components for healthcare providers, defense agencies, and athletics organizations in Hospital-at-Home, RPM, and DTx settings.
- RPM and DTx Software Services: Software services for remote patient monitoring and digital therapeutics, including real-time data transmission to cloud platform, predictive analytics, and clinical dashboard access for healthcare providers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B Enterprise Platform Pricing |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels6 records
INVIZA product offering
Product offeringCore offering
INVIZA sells the INVIZA® CARE M1.0 unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform comprising self-charging smart insoles (InvizaSoles™) with medical-grade optical sensors and edge AI/ML, patient and caregiver mobile apps (InvizaCare™, InvizaSafe™), a HIPAA- and DoD-secure cloud platform (InvizaCloud™) with predictive analytics, and clinical web dashboards (InvizaPortal™). The platform is sold B2B to healthcare providers, defense agencies, and athletic organizations for Hospital-at-Home, RPM, and continuous vital-sign monitoring use cases.
Product overview
INVIZA® offers the INVIZA® CARE M1.0 unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform designed for healthcare and defense applications. The platform integrates five core components: InvizaSoles™ smart insoles (self-charging wearable devices with medical-grade optical sensors and edge AI computing), InvizaSafe™ caregiver mobile app, InvizaCare™ patient mobile app, InvizaCloud™ HIPAA/DoD secure cloud platform with AI/ML analytics, and InvizaPortal™ web dashboards for clinical monitoring. The system enables real-time health monitoring of patients in hospital-at-home settings through continuous vital sign tracking, predictive analytics, and actionable DTx insights promoting physical activity for recovery.
Differentiator
Problem solved
Functional benefit
Brands
- InvizaSoles™: Self-charging, medical-grade smart insoles with AI/ML edge computing for vital sign measurement
- InvizaSafe™
- InvizaCare™
- InvizaCloud™
- InvizaPortal™
- SmartPower™
- PredictiveWellness™
- InvizaBLE Intelligence™
Products and services
- InvizaSoles™ Self-Charging Smart Insoles Self-charging, medical-grade smart insoles with AI/ML edge computing that use piezoelectric materials to convert steps into energy. Features non-invasive optical sensors for measuring vital signs including heart rate, SpO2, body temperature, and a 9-axis IMU for movement tracking. Sold to healthcare providers, defense agencies, and athletic organizations for continuous remote patient monitoring.
- INVIZA® CARE M1.0 Platform Unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform combining smart insoles, mobile apps (InvizaSafe, InvizaCare), cloud platform (InvizaCloud), and web dashboards (InvizaPortal) to enable real-time health monitoring of patients in Hospital-at-Home, RPM, and DTx settings for healthcare and defense customers.
- InvizaCloud™ HIPAA and DoD Secure AI/ML Cloud Platform HIPAA- and DoD-secure AI/ML cloud computing platform that receives patient data via Bluetooth or LTE cellular, performs advanced analytics using artificial intelligence algorithms, and enables licensed medical professionals to remotely monitor patients with predictive analytics for readmission risk, fall prediction, and treatment optimization.
Quantifiable outcome
- 40-49% of US hospitals fined $350M to $535M annually by CMS for readmissions
- +3 more outcomes
Companies that use INVIZA
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
INVIZA technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature7 records
INVIZA partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and supporting.
- Kathy Ireland Small Business Network (kiSBN)corePartnership announced July 21, 2020. Kathy Ireland, Chair, CEO & Chief Designer of kathy ireland Worldwide, announced INVIZA as partner in her newly formed kiSBN. INVIZA designs FashTech MedTech fitness, health, predictive wellness and location trackers with products concealed within apparel, shoes and accessories. Kathy Ireland serves as Chief Global Brand Strategist for INVIZA Health.
- Quanterion SolutionssupportingMilitary Intelligence, Software and Cybersecurity Experts providing DoD applications expertise. Quanterion Solutions is a Senior Program Manager affiliation for Major (ret.) Cully Patch who serves on INVIZA's Technical Advisory Board.
- Spectrum ErgonomicssupportingIndependent Beta-Testing Services provider for product testing and validation.
- IdeastepsolesupportingHigh Volume, Low Cost Polyurethane Insoles Manufacturing partner for production scaling.
- Cornell NanoScale Science and Technology Facility (CNF)supportingResearch partnership with Cornell CNF for energy harvesting technology development. INVIZA's SmartPower technology based on research completed in partnership with Cornell Energy Materials Center with funding from Army Research Laboratory, NSF/EPSCoR, NYSTAR, and NYSERDA.
- University of VermontsupportingResearch partnership with UVM for piezoelectric energy harvesting devices. Dr. Junru Wu (co-founder, MicroGen Systems) was Emeritus Professor at UVM. INVIZA technology based on world-renowned research from UVM and Cornell CNF partnership.
- Forbes Technology CouncilsupportingQaizar Hassonjee, Ph.D. is a member of the Forbes Technology Council, providing thought leadership and visibility opportunities.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
INVIZA competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
INVIZA social profiles
Digital presenceINVIZA compliance and trust
Trust signalCompliance2 records
INVIZA financial estimates
Financial estimateRevenue estimate
Valuation estimate
INVIZA leadership team
Management profileNumber of profiles
Profiles12 records
INVIZA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
INVIZA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about INVIZA
What does INVIZA do?
INVIZA sells the INVIZA® CARE M1.0 unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform comprising self-charging smart insoles (InvizaSoles™) with medical-grade optical sensors and edge AI/ML, patient and caregiver mobile apps (InvizaCare™, InvizaSafe™), a HIPAA- and DoD-secure cloud platform (InvizaCloud™) with predictive analytics, and clinical web dashboards (InvizaPortal™). The platform is sold B2B to healthcare providers, defense agencies, and athletic organizations for Hospital-at-Home, RPM, and continuous vital-sign monitoring use cases.
Is INVIZA a public or private company?
INVIZA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was INVIZA founded?
INVIZA was founded in 2020. It employs 11 to 50 people.
Where is INVIZA based?
INVIZA is headquartered in Fairport, United States, in the North America region.
How does INVIZA make money?
Two revenue lines are on record. INVIZA CARE M1.0 Platform is the primary driver. The others are RPM and DTx Software Services.
Does INVIZA have an API?
No public API is recorded for INVIZA.
What industry is INVIZA in?
INVIZA's product category is Remote Patient Monitoring Platform. Its primary akta.pro industry code is HLACAPAA, Remote Patient Monitoring (RPM) Platforms & Services, with a secondary code of HLALABAF, Chronic Care & Remote Patient Monitoring (RPM) Platforms. Its NAICS code is 621610 and its SIC code is 3841.